Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 2

2(28.6%)

Phase 4

1(14.3%)

7Total

N/A(4)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07290088Phase 2Recruiting

Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients

Role: collaborator

NCT05226858Recruiting

Transesophageal Echocardiography To Diagnose Blunt Traumatic Aortic Injury Traumatic Aortic Injury

Role: collaborator

NCT05286619Phase 2Recruiting

A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)

Role: collaborator

NCT05364112Not ApplicableUnknown

Utilization of Compreflex Wraps in Patients With Chronic Venous Insuffciency

Role: lead

NCT04384042Unknown

Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study

Role: collaborator

NCT04390165Completed

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study

Role: collaborator

NCT02794714Phase 4Withdrawn

Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction

Role: lead

NCT02983344Not ApplicableCompleted

Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia

Role: lead

NCT02586454Not ApplicableCompleted

Analgesic Efficacy of Transmuscular Quadratus Lumborum in Patients Undergoing Total Abdominal Hysterectomy

Role: lead

NCT03061461Not ApplicableUnknown

Radial Extracorporeal Shock Wave Therapy for Chronic Soft Tissue Wounds

Role: lead

All 10 trials loaded